Aquinnah Pharmaceuticals has announced that it has been awarded a $3.4 million grant from the National Institute of Neurological Disorders and Stroke (NINDS) to advance novel therapeutic drug candidates
Neuro biotech Aquinnah Pharmaceuticals has a new vice president of research: Travis Wager, Ph.D., who wore various hats during his 20-year tenure at Pfizer.